Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan Scrambles to Recall SPL-made Heparin

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Under the guidance of Japan's Ministry of Health, Labor and Welfare, Fuso Pharmaceutical Industries, Otsuka Pharmaceutical and Terumo Corp. work to replace their heparin sodium products that contain active ingredients from Scientific Protein Laboratories
Advertisement

Related Content

Japanese Pharma Companies Start Voluntary Recall Of Heparin
Contaminant Discovered In Chinese-Produced Heparin API
Advertisement
UsernamePublicRestriction

Register

SC067916

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel